A Reform Proposal in Need of Reform: A Critique of Thomas Pogge's Proposal for How to Incentivize Research and Development of Essential Drugs
David Bourget (Western Ontario)
David Chalmers (ANU, NYU)
Rafael De Clercq
Jack Alan Reynolds
Learn more about PhilPapers
Public Health Ethics 3 (2):167-177 (2010)
In two recent essays, Thomas Pogge addresses the question of how research and development of essential drugs should be incentivized. Essential drugs are drugs for diseases that ruin human lives. The current incentivizing scheme for such drugs is, according to Pogge, a significant causal factor in bringing about a state of affairs in which millions of people die or suffer from lack of access to essential drugs. Pogge, therefore, suggests a reform plan for how to incentivize research and development of these drugs, and he is of the opinion that implementation of this plan will have a significant positive impact on the global disease burden. This paper is a critical examination of Pogge's reform plan. In the first part of the paper, Pogge's reasons for being dissatisfied with the current incentivizing scheme are spelled out. The reform plan is then presented, and in the final part of the paper, it is argued that the reform plan is flawed at a number of levels
|Keywords||No keywords specified (fix it)|
|Categories||categorize this paper)|
Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
|Through your library|
References found in this work BETA
David Barnard (2002). In the High Court of South Africa, Case No. 4138/98: The Global Politics of Access to Low-Cost AIDS Drugs in Poor Countries. [REVIEW] Kennedy Institute of Ethics Journal 12 (2):159-174.
Aidan Hollis (2008). The Health Impact Fund: A Useful Supplement to the Patent System? Public Health Ethics 1 (2):124-133.
Alan Patten (2005). Should We Stop Thinking About Poverty in Terms of Helping the Poor? Ethics and International Affairs 19 (1):19–27.
Thomas Pogge (2008). Access to Medicines. Public Health Ethics 1 (2):73-82.
Thomas W. Pogge (2005). Human Rights and Global Health: A Research Program. Metaphilosophy 36 (1‐2):182-209.
Citations of this work BETA
Jorn Sonderholm (2010). Ethical Issues Surrounding Intellectual Property Rights. Philosophy Compass 5 (12):1107-1115.
Similar books and articles
Nicole Hassoun (2012). Global Health Impact: A Basis for Labeling and Licensing Campaigns? Developing World Bioethics 12 (3):121-134.
M. Peterson, A. Hollis & T. Pogge (2010). A Critique in Need of Critique. Public Health Ethics 3 (2):178-185.
Pablo Gilabert (2007). Comentarios Sobre la Concepcion de la Justicia Global de Pogge. Revista Latinoamericana de Filosofia 33 (2):205-222.
Jorn Sonderholm (2009). In Defence of Priority Review Vouchers. Bioethics 23 (7):413-420.
Leif Wenar (2010). Realistic Reform of International Trade in Resources. In Alison M. Jaggar (ed.), Thomas Pogge and His Critics. Polity.
Michael Ravvin (2008). Incentivizing Access and Innovation for Essential Medicines: A Survey of the Problem and Proposed Solutions. Public Health Ethics 1 (2):110-123.
J. Sonderholm (2011). Advance Monopoly Commitment? Public Health Ethics 4 (3):297-302.
Added to index2010-08-11
Total downloads35 ( #48,495 of 1,098,965 )
Recent downloads (6 months)7 ( #33,712 of 1,098,965 )
How can I increase my downloads?